Drug Trial Radar · NCT03420014
Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA)
Last checked: Nov 19, 2026Latest source record: Oct 10, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
114
Planned (sponsor's estimate)
Start
Dec 27, 2018
Primary completion
Dec 2024
Study completion Dec 2025
Sponsor
- Lead sponsor
- Philogen S.p.A.Industry
- Sponsor type
- Industry
- First posted
- Feb 5, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 16 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The present study is an open-label, randomized, controlled, two-arm multi-center study of the efficacy of L19TNF treatment in combination with doxorubicin versus doxorubicin alone in metastatic leiomyosarcoma patients.
Conditions
- Leiomyosarcoma
Interventions
DoxorubicinDrug
75 mg/m2 doxorubicin will be administered once every 3 weeks (Day 1 of every 21-days cycle).
L19TNF plus doxorubicinCombination product
13 μg/kg L19TNF will be administered on day 1, 3 and 5 of every 21-days cycle in combination with 60 mg/m2 doxorubicin on day 1 of every 21-days cycle.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression free survival (PFS)Time frame: From randomization up to week 72
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Mayo Clinic Hospital
Phoenix, Arizona · Recruiting
Sarcoma Oncology Research Center (SORC) Cancer Center of Southern California
Santa Monica, California · Recruiting
Mayo Clinic Hospital
Jacksonville, Florida · Recruiting
Mayo Clinic
Rochester, Minnesota · Recruiting
Washington University
St Louis, Missouri · Recruiting
Rutgers Cancer Institute of New Jersey 195 Little Albany Street New Brunswick, NJ 08901 Room 2031
New Brunswick, New Jersey · Recruiting
Ohio State University Comprehensive Cancer Center
Columbus, Ohio · Recruiting
Seattle Cancer Care Alliance 825 Eastlake Ave. E. Seattle, WA 98109 Mail Stop CE2-128
Seattle, Washington · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.